EMVision Unlocks $1.17M Government Grant With No Dilution to Shareholders
EMVision confirms $1.17M non-dilutive IGP grant instalment
EMVision Medical Devices Limited (ASX: EMV) has confirmed it has met the milestone requirements to trigger its next grant instalment under the Australian Government’s Industry Growth Program (IGP), with a payment of $1.17 million expected this month (May 2026).
The funding is non-dilutive, meaning no shareholder dilution and no debt obligation. The instalment forms part of the $5 million IGP Commercialisation and Growth Grant awarded to EMVision in June 2025 to support the global commercialisation of the First Responder Brain Scanner, the company’s lightweight pre-hospital brain scanning device designed for use in road and aeromedical settings.
When big ASX news breaks, our subscribers know first
Understanding IGP grant funding and what it means for EMVision investors
What is the Industry Growth Program?
The Industry Growth Program is an Australian Government initiative that provides funding to support the commercialisation and growth of innovative companies. Importantly, recipients do not give up equity and are not required to repay the funds.
For EMVision specifically, payments are made quarterly in advance, based on forecast eligible expenditure, adjusted for any unspent funds from prior periods. Each payment is subject to demonstrating satisfactory progress against agreed program milestones. This means funding is not automatic. EMVision was required to demonstrate continued execution on its First Responder product development and commercialisation programme to unlock this tranche.
EMVision’s grant funding position at a glance
- Total IGP grant awarded: $5 million (June 2025)
- Received prior to this instalment: $1 million
- This instalment: $1.17 million
- Remaining available: $2.83 million
| Grant Stage | Amount | Status | Cumulative Received |
|---|---|---|---|
| Initial instalment | $1.00M | Received | $1.00M |
| Current instalment | $1.17M | Expected May 2026 | $2.17M |
| Remaining available | $2.83M | Subject to milestones | — |
| Total IGP grant | $5.00M | Awarded June 2025 | — |
Milestone execution reinforces First Responder commercialisation progress
The triggering of this instalment reflects more than the passage of time. It demonstrates that EMVision has continued to execute against its agreed program milestones, satisfying the conditions required under the IGP grant agreement.
The First Responder Brain Scanner addresses a recognised gap in pre-hospital care: the ability to diagnose stroke in road and aeromedical settings, where speed is critical to patient outcomes. Stroke occurs when blood flow to the brain is interrupted, either by a blocked vessel (ischemic stroke) or bleeding into the brain (haemorrhagic stroke). Because these two stroke types require different treatments, rapid and accurate point-of-care diagnosis is clinically significant.
With $2.83 million remaining under the IGP, EMVision retains continued non-dilutive support for the program’s global commercialisation objectives. Each future instalment will similarly require satisfactory milestone progress before it is released.
The next major ASX story will hit our subscribers first
What’s next for EMVision
Further grant tranches remain subject to continued milestone achievement under the IGP agreement, with the remaining $2.83 million providing ongoing non-dilutive support for the First Responder programme. EMVision’s broader mission is to help transform the timely diagnosis and treatment of stroke and other time-sensitive medical emergencies at the point-of-care. Continued execution against its programme milestones will be the key determinant of when, and whether, remaining funds are drawn down.
Don’t Miss the Next ASX Healthcare Breakthrough
Big News Blast delivers FREE breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ investors already staying ahead of the market. Click the “Free Alerts” button at StockWire X to start receiving alerts the moment market-moving announcements drop.